Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $40 | $11 | $69 | $157 |
| Short-Term Investments | $17 | $37 | $0 | $0 |
| Receivables | $0 | $0 | $6 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $3 |
| Total Curr. Assets | $57 | $48 | $75 | $160 |
| Property Plant & Equip (Net) | $0 | $1 | $3 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $21 | $22 | $1 | $1 |
| Tax Assets | $31 | $33 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $53 | $55 | $4 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $110 | $104 | $79 | $168 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $14 |
| Short-Term Debt | $1 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $15 | $12 |
| Total Curr. Liab. | $1 | $1 | $16 | $27 |
| LT Debt | $2 | $2 | $4 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $4 | $5 |
| Total Liabilities | $2 | $3 | $20 | $32 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$384 | -$392 | -$435 | -$366 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $492 | $492 | $494 | $502 |
| Total Equity | $108 | $101 | $59 | $136 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $110 | $104 | $79 | $168 |
| Net Debt | -$37 | -$8 | -$64 | -$152 |